清胰汤类方不同给药途径治疗重症急性胰腺炎疗效指标的网状Meta分析OA
Network Meta-analysis on efficacy indicators of different administration routes of Qingyi Tang in treating severe acute pancreatitis
目的:运用网状Meta分析清胰汤类方不同给药途径对重症急性胰腺炎(severe acute pancreatitis,SAP)的疗效及安全性进行评价;方法:计算机检索PubMed、EMbase、Cochrane、Web of Science、中国知网、万方数据、中国生物医学文献数据库、维普数据库.检索时间自各数据库建库至 2025年8月20日.采用改良Jadad 量表和 Cochrane 风险偏倚工具对纳入文献进行质量评价,采用 RevMan 5.4、Stata 18 软件进行数据分析.对主要结局临床疗效、急性炎症反应相关肠功能指标、病死率,次要结局指标血淀粉酶恢复时间进行分析,采用曲线下面积(SUCRA)对干预措施进行排序,采用漏斗图检验检测发表偏倚等.结果:本研究共纳入 59 篇文献,共包括 4 588 例患者,均为双臂研究,包含了 5 种治疗方案,涉及常规西医治疗措施、常规西医治疗措施联合清胰汤类胃管注入、常规西医治疗措施联合清胰汤类胃管注入或灌肠、常规西医治疗措施联合清胰汤类空肠管鼻饲、常规西医治疗措施联合清胰汤类灌肠;从临床有效率、首次排便时间、肠功能恢复时间、血淀粉酶恢复时间及病死率 5 项指标开展分析,其中报道了33项临床有效率,40项首次排便时间,33项肠功能恢复时间,血淀粉酶恢复时间19篇,病死率19篇.结果显示,相较于单纯常规西医治疗,清胰汤类方联合治疗可显著提升临床有效率、缩短各项恢复时间并降低病死率;不同给药途径疗效各有侧重,SUCRA 排序显示:空肠管鼻饲在提高有效率、促进肠功能恢复方面最优,胃管注入+灌肠缩短首次排便时间效果最佳,空肠管鼻饲促进肠功能恢复最快,胃管注入利于血淀粉酶恢复且病死率最低.结论:清胰汤类方不同给药途径联合西医治疗 SAP疗效显著,临床可依据患者核心需求个体化选择给药方式;受纳入研究质量限制,未来需开展高质量、大样本、多中心随机对照试验(RCT)进一步验证.
Objective:To evaluate the efficacy and safety of different administration routes of Qingyi Tang(清胰汤)-like prescriptions in the treatment of severe acute pancreatitis(SAP)using network meta-analysis.Methods:Computerized searches were conducted in PubMed,EMbase,Cochrane,Web of Science,CNKI,Wanfang,China Biology Medicine disc,and VIP databases from the establishment of each database to August 20,2025.The quality of the included studies was evaluated using the modified Jadad scale and the Cochrane risk of bias tool.Data analysis was performed using RevMan 5.4 and Stata 18 software.The primary outcome measures were clinical efficacy,mortality,and acute inflammatory response and intestinal function indicators.The secondary outcome measure was the time for blood amylase to return to normal.The surface under the cumulative ranking curve(SUCRA)was used to rank the intervention measures,and funnel plots were used to test for publication bias.Results:A total of 59 studies involving 4 588 patients were included,all of which were two-arm trials covering five treatment regimens:conventional Western medicine,conventional Western medicine combined with gastric tube administration of Qingyi Decoction,conventional Western medicine combined with gastric tube administration or enema of Qingyi Decoction,conventional Western medicine combined with nasojejunal tube feeding of Qingyi Decoction,and conventional Western medicine combined with enema of Qingyi Decoction.The analysis covered five indicators:clinical effective rate,time to first defecation,intestinal function recovery time,blood amylase recovery time,and mortality,with 33,40,33,19 and 19 reports respectively.Compared with conventional Western medicine alone,combined treatment with Qingyi Decoction significantly improved the clinical effective rate,shortened various recovery times,and reduced mortality.Different administration routes had distinct advantages.SUCRA ranking indicated that nasojejunal tube feeding was optimal for improving the effective rate and promoting intestinal function recovery,gastric tube administration combined with enema performed best in shortening the time to first defecation,nasojejunal tube feeding accelerated intestinal function recovery most rapidly,and gastric tube administration facilitated blood amylase recovery and yielded the lowest mortality.Conclusion:The combination of different administration routes of Qingyi Tang-like formula and conventional Western medical treatment measures in the treatment of SAP has obvious advantages in improving the clinical effective rate,shortening the first defecation time,intestinal function recovery time and amylase recovery time,and reducing the mortality rate.It can be used as one of the clinical treatment plans of integrated traditional Chinese and Western medicine.Due to the limitations of the sample size,quality of the included studies,and the lack of more specific direct pairwise comparisons of traditional Chinese medicine administration routes and outcome indicators,the above conclusions need to be further verified by more high-quality,large-sample,and multi-center clinical randomized controlled trials in future research.
奚锦要;覃树辉
广西中医药大学附属瑞康医院,广西 南宁,530011广西中医药大学附属瑞康医院,广西 南宁,530011
医药卫生
重症急性胰腺炎清胰汤不同给药途径网状Meta分析
Severe acute pancreatitisQingyi TangDifferent administration routesNetwork Meta-analysis
《中医临床研究》 2026 (17)
51-65,15
国家自然科学基金地区项目(3226090033).
评论